Skip to main content
Livermore
Livermore
ZHEN

FMR LLC

SEC CIK
0000315066
Latest filing
Aug 13, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by FMR LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
1,457,158
Value
$723.8M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VRTX by FMR LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,457,158$723.8M<0.1%−563,107−27.9%ReducedHolders
Q1 20262,020,265$902.1M<0.1%−192,331−8.7%ReducedHolders
Q4 20252,212,596$1.00B0.1%−1,091,172−33.0%ReducedHolders
Q3 20253,303,768$1.29B0.1%−3,102,604−48.4%ReducedHolders
Q2 20256,406,372$2.85B0.2%−1,320,812−17.1%ReducedHolders
Q1 20257,727,184$3.75B0.2%−1,491,862−16.2%ReducedHolders
Q4 20249,219,046$3.71B0.2%−1,305,967−12.4%ReducedHolders
Q3 202410,525,013$4.89B0.3%−204,415−1.9%ReducedHolders
Q2 202410,729,428$5.03B0.3%+55,908+0.5%AddedHolders
Q1 202410,673,520$4.46B0.3%−2,305,991−17.8%ReducedHolders
Q4 202312,979,511$5.28B0.4%−1,380,926−9.6%ReducedHolders
Q3 202314,360,437$4.99B0.4%−268,229−1.8%ReducedHolders
Q2 202314,628,666$5.15B0.4%−1,647,189−10.1%ReducedHolders
Q1 202316,275,855$5.13B0.5%−1,590,436−8.9%ReducedHolders
Q4 202217,866,291$5.16B0.5%+500,268+2.9%AddedHolders
Q3 202217,366,023$5.03B0.5%+613,012+3.7%AddedHolders
Q2 202216,753,011$4.72B0.5%+3,571,298+27.1%AddedHolders
Q1 202213,181,713$3.44B0.3%+4,087,860+45.0%AddedHolders
Q4 20219,093,853$2.00B0.1%+4,216,754+86.5%AddedHolders
Q3 20214,877,099$884.7M0.1%−956,964−16.4%ReducedHolders
Q2 20215,834,063$1.18B0.1%−4,337,179−42.6%ReducedHolders
Q1 202110,171,242$2.19B0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.